ARATA Corporation
ARATA is Japan’s second-largest wholesaler of daily necessities, cosmetics and pet supplies. It buys from about 1,100 manufacturers and delivers daily to roughly 3,370 retailers, with a 9.7% gross margin and 1.3% OP margin. On May 14, 2026 it announced a 2030 medium-term plan for margin recovery, describing FY3/27 as the earnings trough.
Company
ARATA Corporation
株式会社あらた
Japan’s second-largest wholesaler of daily necessities, cosmetics and pet supplies, connecting manufacturers with retailers.
- Last Close
- ¥2,570
- Jul 16, 2026 · −30% from Sep-24 peak · +8% off the Jun-26 low
- Market Cap / enterprise value (EV)
- ¥86.0bn / ¥95.3bn EV
- net debt ¥9.2bn (11% of cap) · 33.5M sh ex-treasury
- EV / OP · forward
- 8.7x
- on FY03/27 OP ¥11.0bn · 7.2x trailing · core 7.4x
- ROCE · trailing
- 8.2%
- down from 10.4% → 10.0% · ROE 8.4%
- OP Margin · group
- 1.3% · grp
- FY03/27 guide 1.1% · ~9.7% gross margin
- Shares & Float
- 33.5M sh · foreign ~22%
- no controlling parent · Fidelity value fund 3.29%
What does ARATA do?
ARATA is Japan's second-largest wholesaler of daily necessities, cosmetics, household goods and pet supplies, behind PALTAC. It is the middle layer of distribution: it buys from about 1,100 manufacturers and delivers to roughly 3,370 retailers across the country. Drugstores, home centers and supermarkets are its main customers. ARATA runs as a single business, formed in 2002 by combining three regional wholesalers and expanded since by acquiring more.
ARATA earns a spread. It buys goods in bulk, stores them, delivers them daily through its own temperature-controlled network, and helps stores plan what goes on the shelf. Gross margin is only about 9.7% and OP margin about 1.3%, so it makes a little money on very large volume. Its extra value is data: ARATA analyzes point-of-sale records to design shelf plans, and it carries a growing book of exclusive lines that rivals cannot stock, about 7.8% of sales.
The company grows in three ways. It consolidates a fragmenting wholesale industry by buying smaller rivals. It deepens its data edge — in December 2025 it joined the True Data alliance, a shared purchase-record pool covering about 60 million people. And it has moved upstream: in January 2026 it bought msh, the maker of the Love Liner cosmetics brand, so it now owns product rather than only carrying it.
FY03/26 was the year ARATA crossed ¥1trn of revenue, at ¥1,004.7bn, a 4.1% annual growth rate over three years. But OP fell 11.9% YoY to ¥13.2bn, and the company guides FY03/27 lower still, to ¥11.0bn — it calls FY03/27 the bottom. ROCE has slipped from 10.4% to 8.2% over three years as the margin thinned. ARATA also carries ¥9.2bn of net debt, the only distributor among its peers not in a net-cash position, and its shares trade at 0.69x book value.
For an investor the question is whether this is the low point. ARATA earns a 1.3% margin. Its shares trade below book value and at 8.7x forward EV/OP. That is cheap if profit recovers from here. It is a poor buy if ARATA’s retail customers keep taking a larger share of the margin each year.
What has driven the stock over the past two years?
The revenue milestone could not offset a structurally thin margin.
01 · When investors paid up for the ¥1-trillion story ARATA rose to a post-split high of ¥3,685 on September 10, 2024. The 2:1 split that January had widened the float and lowered the entry price, and investors bought the company's approach to ¥1trn of revenue and its record of rolling up smaller wholesalers. Demand for daily necessities looked steady and hard to disrupt. At the peak, EV/OP was roughly 9x on the guidance then in force.
02 · When the thin margin came into focus Through 2025 ARATA kept growing sales, but its costs grew faster. Warehouse spending and freight rose, and so did the center fees† that retailers charge ARATA for moving goods through the retailers’ own distribution centers. OP margin drifted down to about 1.3%. Investors came to see 1.3% as the level this business would keep earning, because ARATA has little room to raise its prices against big retail customers, and the shares fell through the year.
03 · The February 2026 guidance cut On February 10, 2026, after the close, ARATA cut its FY03/26 OP guidance by 17.6%. Coming after two years of falling margin, the cut told investors the higher costs were likely here to stay. Investors kept selling, and the de-rating continued into the spring.
04 · Where the stock stands now ARATA reported FY03/26 results on May 14 — revenue past ¥1trn but OP down 11.9% YoY — and guided FY03/27 as an earnings trough alongside its 2030 medium-term plan. The slide bottomed at ¥2,382 on June 22, 2026, then recovered to ¥2,570 by July 16. Over 24 months ARATA fell 26.6% while the TOPIX index rose 47.0%, one of the worst showings against the market. Whether that gap is deserved depends on whether ARATA’s profit recovers or stays near this low level.
What investors disagree about
Scale, margin recovery, and acquisition returns determine what ARATA is worth.
ARATA sits between about 1,100 makers and 3,370 retailers, buying in bulk, warehousing, and delivering daily on a spread of roughly 1.3%. As drugstore and supermarket chains merge, they gain the scale to run logistics themselves. What matters is whether ARATA's network stays cheaper than doing it in-house.
- ARATA combines scale, retail data, and a national temperature-controlled network that few retailers can rebuild.
- ARATA is the second-largest of only a few national wholesalers, so when two retailers merge, the combined chain still orders through ARATA and more goods pass through its warehouses.
- Its point-of-sale shelf plans and exclusive lines add service a plain logistics contract cannot.
- Big retailers such as Tsuruha, now inside the Welcia and Aeon group, can build their own delivery and charge ARATA a fee to use it.
- On a 1.3% margin ARATA cannot absorb a higher fee without losing money.
- Separately, some makers now sell straight to large retailers, cutting ARATA out of those orders.
In FY03/26 ARATA's sales rose 1.9% YoY but its overheads rose 3.6% and freight 5.1%, so OP fell and margin slipped to 1.3%. FY03/27 guidance puts it at 1.1%. What matters is whether inflation and one-off costs caused this, or whether retail buyer-power has set a lower ceiling.
- The squeeze looks temporary. A Hiroshima logistics-center move and acquisition fees weighed on FY03/26, while a richer mix of cosmetics and exclusive products should carry higher margins. Management is also spending before the expected recovery.
- The pressure may be structural. Sales grew 1.9%, but overhead grew 3.6% and freight 5.1%, continuing a two-year pattern. ARATA has not yet shown that it can make its largest customers absorb those higher costs.
In January 2026 ARATA bought msh, maker of the Love Liner eye-makeup brand, adding about ¥8.6bn of goodwill. A distributor was buying a brand it used only to carry. What matters is whether owning the product captures the maker's margin, or stretches ARATA outside what it does well.
- ARATA already reaches roughly 3,370 retailers, so it can put Love Liner, Polite, and D-Nee on more shelves than msh could alone and capture the maker's margin alongside the distribution spread.
- Cosmetics carry a higher gross margin than daily necessities and deepen ARATA's category-data edge.
- ARATA paid ¥8.6bn of goodwill plus integration cost with no disclosed return hurdle for the deal.
- Owning and marketing a brand is a different skill from moving other makers' boxes, and a wholesaler's buyers may not run a cosmetics label well.
- The purchase lands while the margin is already falling.
What is changing in who owns it, who buys from it, and the edge?
- The 2:1 split in January 2024 widened the float and lowered the entry price, opening the register to more investors.
- ARATA has no controlling parent; its largest holder is a passive trust bank at 11.6%.
- Foreign ownership runs near 22%, and it includes Fidelity Low-Priced Stock at 3.29% — a value fund already holding a stock at 0.69x book.
- The supplier Lion holds 2.79% as a cross-holder.
- The drugstore channel is 52% of sales and rising, and Tsuruha is the only account above 10%, at 13.6%.
- The book is concentrated in the fastest-growing retail format.
- Tsuruha is folding into the Welcia and Aeon orbit, which raises the buyer power of ARATA's single largest account.
- A bigger customer can press harder on price and on center fees.
- ARATA joined the True Data alliance, a shared purchase-record pool covering about 60 million people, deepening the category data behind its shelf plans.
- Better data makes its store-front marketing harder to replace.
- The msh acquisition moved ARATA upstream into owning the Love Liner cosmetics brand, adding higher-margin product to a thin-spread book.
Disclosure & Capital Levers
The next disclosures can show whether today's trough valuation is justified.
- ARATA guides FY03/27 as the bottom, with OP of ¥11.0bn, because the medium-term plan spends on growth and integration first. A later margin recovery would show that those costs were temporary.
- Management has newly named ROIC as its discipline. A FY03/27 buyback or a disclosed reduction in policy shareholdings would put that discipline into practice.
- ARATA's gross margin is only about 9.7% and its OP margin 1.3%, so a richer product mix is the main lever it controls.
- Owning msh (Love Liner, the top-selling eye-liner) and Polite, alongside its own D-Nee brand, lets ARATA sell higher-margin cosmetics through roughly 3,370 retailers rather than only carrying others'.
Scenario Pathways
The cases start from ¥2,570 and FY03/27 OP guidance.
Even here the ¥112 dividend yields 4.4% at the current price, and the payout has risen eleven years running.
The top of the range, ¥3,636, sits below the September 2024 peak of ¥3,685 — reclaiming the record would need the FY03/27 trough clearly behind the company.
This is not investment advice.
Japan Investor Interface Co., Ltd. (“JII”) is an investor-relations (IR) consultancy. JII is not a registered investment advisor, financial advisor, broker-dealer or securities firm in any jurisdiction. JII is not registered as a Financial Instruments Business Operator under Japan’s Financial Instruments and Exchange Act and does not hold an Investment Advisory and Agency Business registration. JII does not provide investment advice or solicit the purchase, sale or holding of any security.
JII Compounders is editorial content for educational and research purposes. Each company report examines how the market has received public disclosures by Japanese listed companies. The intended readers are IR practitioners, finance students, journalists and people interested in corporate disclosure. The content does not recommend, propose or solicit the purchase, sale or holding of any security, derivative or other financial instrument. Price levels, scenarios, valuation multiples and peer comparisons illustrate analytical methods and do not express JII’s investment judgment.
Using this information. The information may be incomplete, out of date or incorrect. Forward-looking statements are uncertain. Past share-price performance does not indicate future results. Estimates and scenario values are not forecasts and may not materialize.
Use of this site. Reading this publication does not create an advisory, fiduciary or other professional relationship between the reader and JII. Before making investment, tax, accounting, legal or other decisions, consult appropriately qualified professionals as necessary.
Trademarks and data. Company names, logos, ticker symbols and product names belong to their respective owners. Share-price data is licensed from third-party providers. TradingView is a trademark of TradingView, Inc.